Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 65601-65650 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06099756
Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)
N/A
Recruiting
2,000 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2024
1 condition
2 sponsors
3 locations
NCT05873686
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
PHASE1
Recruiting
140 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2027
6 conditions
1 sponsor
7 locations
NCT06054035
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
PHASE4
Recruiting
170 participants
Started: Oct 26, 2023 · Completed: Sep 30, 2027
3 conditions
4 sponsors
9 locations
NCT05923489
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
NA
Recruiting
2,618 participants
Started: Oct 26, 2023 · Completed: Oct 15, 2029
1 condition
9 sponsors
1 location
NCT06247605
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
PHASE3
Recruiting
243 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2029
1 condition
1 sponsor
1 location
NCT05655091
Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
PHASE2
Recruiting
36 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06004856
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
PHASE3
Recruiting
195 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
45 locations
NCT05725655
Hot Water Immersion After Myocardial Infarction
NA
Recruiting
30 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05792007
Study of the Medullary Microenvironment in Acute Childhood Leukemia
NA
Recruiting
40 participants
Started: Oct 26, 2023 · Completed: Oct 24, 2028
2 conditions
1 sponsor
3 locations
NCT05848895
OPT-IN: Osteopathic Plagiocephaly Treatment for Infants and Neonates
NA
Recruiting
122 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06911697
Study on c-Met Targeted PET/CT Imaging in NSCLC
NA
Recruiting
88 participants
Started: Oct 26, 2023 · Completed: Jun 28, 2025
2 conditions
2 sponsors
1 location
NCT05984888
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
NA
Recruiting
43 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05929859
Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders
PHASE1/PHASE2
Recruiting
84 participants
Started: Oct 26, 2023 · Completed: Feb 29, 2028
1 condition
4 sponsors
1 location
NCT06066905
A Study of Chidamide With AZA in MRD Positive AML After Transplant
NA
Recruiting
60 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06103201
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
PHASE1
Recruiting
15 participants
Started: Oct 26, 2023 · Completed: Nov 26, 2027
2 conditions
1 sponsor
1 location
NCT06049212
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)
PHASE1
Recruiting
30 participants
Started: Oct 26, 2023 · Completed: Jan 29, 2027
5 conditions
1 sponsor
7 locations
NCT06106360
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
N/A
Recruiting
100 participants
Started: Oct 26, 2023 · Completed: Dec 26, 2025
2 conditions
1 sponsor
1 location
NCT06182696
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
PHASE1/PHASE2
Recruiting
83 participants
Started: Oct 26, 2023 · Completed: Aug 31, 2028
1 condition
1 sponsor
5 locations
NCT06143007
A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors
PHASE1
Recruiting
42 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
2 locations
NCT05935371
Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
N/A
Recruiting
87 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2025
7 conditions
2 sponsors
1 location
NCT05939999
Effects of Elastic Tape on Pulmonary Rehabilitation of Patients with Chronic Obstructive Pulmonary Disease
NA
Recruiting
42 participants
Started: Oct 26, 2023 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT06725758
Two-part, First-in-Human Study on ODM-212 in Subjects with Selected Advanced Solid Tumours
PHASE1/PHASE2
Recruiting
315 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT07007741
Digital Therapy for Fatty Liver Disease
NA
Recruiting
120 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05799040
Evaluation of the Effectiveness of the Self-developed Pulmonary Lobar Ventilation Detector
N/A
Recruiting
40 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06190184
Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions
NA
Recruiting
60 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2024
9 conditions
1 sponsor
1 location
NCT05985109
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
PHASE2
Recruiting
98 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05987423
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
PHASE3
Active, not recruiting
131 participants
Started: Oct 26, 2023 · Completed: Jul 1, 2026
2 conditions
1 sponsor
46 locations
NCT06094582
Knowledges and Use of Cannabidiol in Older Adults
N/A
Recruiting
140 participants
Started: Oct 26, 2023 · Completed: May 31, 2024
2 conditions
1 sponsor
1 location
NCT05899608
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
PHASE3
Recruiting
1,080 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
219 locations
NCT06109246
The Patient Enablement Instrument for Back Pain Turkish Version, Validity and Reliability Study
N/A
Not yet recruiting
60 participants
Started: Oct 26, 2023 · Completed: Dec 30, 2023
1 condition
1 sponsor
1 location
NCT06100328
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
N/A
Recruiting
40 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2030
1 condition
1 sponsor
1 location
NCT06009523
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
NA
Recruiting
50 participants
Started: Oct 26, 2023 · Completed: Dec 1, 2027
1 condition
1 sponsor
2 locations
NCT05952271
Herpes Zoster Hospitalizations in Italy
N/A
Recruiting
72,000 participants
Started: Oct 26, 2023 · Completed: Jul 30, 2025
2 conditions
2 sponsors
1 location
NCT06104046
Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis
N/A
Not yet recruiting
50 participants
Started: Oct 26, 2023 · Completed: Mar 31, 2025
1 condition
1 sponsor
0 locations
NCT05710666
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
PHASE2
Active, not recruiting
11 participants
Started: Oct 26, 2023 · Completed: Mar 30, 2028
1 condition
1 sponsor
5 locations
NCT05440864
Durvalumab and Tremelimumab in Resectable HCC
PHASE2
Recruiting
28 participants
Started: Oct 26, 2023 · Completed: Nov 30, 2026
1 condition
3 sponsors
3 locations
NCT06225856
An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
PHASE1
Recruiting
96 participants
Started: Oct 26, 2023 · Completed: Dec 30, 2026
2 conditions
1 sponsor
1 location
NCT06057376
Impact of Two Dietary Interventions on Simple Carbohydrate Intolerance
NA
Recruiting
40 participants
Started: Oct 26, 2023 · Completed: Feb 28, 2026
1 condition
3 sponsors
1 location
NCT06227962
Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
N/A
Enrolling by invitation
660 participants
Started: Oct 26, 2023 · Completed: Mar 31, 2028
3 conditions
1 sponsor
1 location
NCT06401850
Polycystic Ovary Syndrome and Education
NA
Recruiting
70 participants
Started: Oct 26, 2023 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT06001242
The Relationship Between Upper Extremity Explosive Power and Trunk Muscles in Volleyball Players
N/A
Not yet recruiting
30 participants
Started: Oct 26, 2023 · Completed: Aug 26, 2025
3 conditions
1 sponsor
1 location
NCT06019923
Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
N/A
Recruiting
100 participants
Started: Oct 26, 2023 · Completed: Sep 10, 2027
1 condition
1 sponsor
1 location
NCT06026319
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
PHASE1
Recruiting
24 participants
Started: Oct 26, 2023 · Completed: Jan 1, 2028
10 conditions
1 sponsor
1 location
NCT05674994
Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
PHASE3
Recruiting
110 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
29 locations
NCT06895291
Whole Body MRI in Oncology
N/A
Recruiting
1,000 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2031
6 conditions
1 sponsor
3 locations
NCT05834244
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
PHASE1
Recruiting
32 participants
Started: Oct 26, 2023 · Completed: Jun 30, 2028
1 condition
1 sponsor
2 locations
NCT06495281
Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients
N/A
Recruiting
3,000 participants
Started: Oct 26, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05632406
Breathing & Blood Pressure
N/A
Recruiting
80 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT06112041
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)
PHASE2
Not yet recruiting
29 participants
Started: Oct 25, 2023 · Completed: Oct 30, 2026
2 conditions
1 sponsor
1 location
NCT06028659
Investigation of in Vivo Endogenous and/or Exogenous Production of Phenolic Metabolites Using (un)Targeted Metabolomics
NA
Recruiting
30 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
1310
1311
1312
1313
1314
1315
1316
More pages
2369
Next